Search Result "MPTP"

α-Synuclein- and MPTP-Generated Rodent Models of Parkinsons Disease and the Study of Extracellular Striatal Dopamine Dynamics: A Microdialysis Approach

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9 Issue: 4 Year: 2010 Page: 482-490
Author(s): Gianfranco Bazzu, Giammario Calia, Giulia Puggioni, Ylenia Spissu, Gaia Rocchitta, Patrizia Debetto, Jessica Grigoletto, Morena Zusso, Rossana Migheli, Pier Andrea Serra, Maria Speranza Desole, Egidio Miele

Research Article

Evaluation of Neurobehavioral and Biochemical Parameters of Poly- Herbal Formulation on MPTP-Intoxicated Mice for the Treatment of PD

Journal: Current Bioactive Compounds
Volume: 16 Issue: 9 Year: 2020 Page: 1290-1298
Author(s): Amit K. Srivastava,Arif Naseer,Amresh Gupta

Potent Neuroprotective Activity of Monoterpene Derived 4-[(3aR,7aS)- 1,3,3a,4,5,7a-Hexahydro-3,3,6-trimethylisobenzofuran-1-yl]-2-methoxyphenol in MPTP Mice Model

Journal: Letters in Drug Design & Discovery
Volume: 11 Issue: 5 Year: 2014 Page: 611-617
Author(s): Alla V. Pavlova, Irina V. Il'ina, Ekaterina A. Morozova, Dina V. Korchagina, Svetlana Yu. Kurbakova, Irina V. Sorokina, Tatyana G. Tolstikova, Konstantin P. Volcho, Nariman F. Salakhutdinov

Research Article

Comparative Assessment of Polyherbal Formulation and Mucuna pruriens Extract as Neuroprotectant by Using MPTP Screening Mouse Model ofParkinson’s Disease

Journal: Current Bioactive Compounds
Volume: 18 Issue: 7 Year: 2022 Page: 78-86
Author(s): Amit Kishor Srivastava

The Intranasal Administration of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP): A New Rodent Model to Test Palliative and Neuroprotective Agents for Parkinsons disease

Journal: Current Pharmaceutical Design
Volume: 17 Issue: 5 Year: 2011 Page: 489-507
Author(s): Rui D. S. Prediger, Aderbal S. Aguiar, Eduardo L. G. Moreira, Filipe C. Matheus, Adalberto A. Castro, Roger Walz, Andreza F. De Bem, Alexandra Latini, Carla I. Tasca, Marcelo Farina, Rita Raisman-Vozari

Long Non-coding RNA HOTAIR Promotes Parkinson's Disease Induced by MPTP Through up-regulating the Expression of LRRK2

Journal: Current Neurovascular Research
Volume: 13 Issue: 2 Year: 2016 Page: 115-120
Author(s): Sen Liu,Bei Cui,Zhen-xia Dai,Peng-ke Shi,Zhao-hui Wang,Yuan-yuan Guo

Review Article

Neurotoxic Mechanism and Shortcomings of MPTP, 6-OHDA, Rotenone and Paraquat-induced Parkinson’s Disease Animal Models

Journal: Venoms and Toxins
Volume: 1 Issue: 1 Year: 2021 Page: 27-40
Author(s): Samuel Kumi Okyere,Chaorong Zeng,Dong Yue,Yanchun Hu

A PPAR-β/δ Agonist is Neuroprotective and Decreases Cognitive Impairment in a Rodent Model of Parkinson’s Disease

Journal: Current Neurovascular Research
Volume: 11 Issue: 2 Year: 2014 Page: 114-124
Author(s): Nihar R. Das,Rahul P. Gangwal,Mangesh V. Damre,Abhay T. Sangamwar,Shyam S. Sharma

Research Article

Combination of Peroxisome Proliferator-activated Receptor Gamma (PPARγ) Agonist and PPAR Gamma Co-Activator 1α (PGC-1α) ActivatorAmeliorates Cognitive Deficits, Oxidative Stress, and Inflammation in Rodent Model of Parkinson’s Disease

Journal: Current Neurovascular Research
Volume: 18 Issue: 5 Year: 2021 Page: 497-507
Author(s): Shyam Sunder Sharma,Mahendra Bishnoi,Pragyanshu Khare,Bhupesh Vaidya,Nihar Ranjan Das

Research Article

Protectors of the Mitochondrial Permeability Transition Pore Activated by Iron and Doxorubicin

Journal: Current Cancer Drug Targets
Volume: 21 Issue: 6 Year: 2021 Page: 514-525
Author(s): Tatiana A. Fedotcheva,Nadezhda I. Fedotcheva

Previous   Next

Go To   Results 1 - 1 of 1338

Apply Filters

Volume Years
Article Type
Publication Title
Subject Title

Content Type


© 2024 Bentham Science Publishers | Privacy Policy